Publication | Closed Access

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

ThrombosisCardiovascular DiseaseMedicinePharmacologyFibrinolysisPharmacotherapyCoagulopathyAtrial FibrillationClinical EventsPublic HealthStrokeAnticoagulantApixaban Versus Warfarin